Aberrant DNA methylation of tumor-related genes in oral rinse

Cancer

Volumn 118, Issue 17, 2012, Pages 4298-4308

  Nagata, Satoshi ^a   Hamada, Tomofumi ^b   Yamada, Norishige ^c   Yokoyama, Seiya ^a   Kitamoto, Sho ^a   Kanmura, Yuji ^a   Nomura, Masahiro ^a   Kamikawa, Yoshiaki ^b   Yonezawa, Suguru ^a   Sugihara, Kazumasa ^a,b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

DNA methylation; epigenetics; oral cancer; oral rinse; oral squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR; FOLLISTATIN RELATED PROTEIN; MEMBRANE PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; RETINOIC ACID RECEPTOR BETA; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; DNA METHYLATION; EARLY DIAGNOSIS; ECAD GENE; EPIGENETICS; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MGMT GENE; MICROCHIP ELECTROPHORESIS; MOUTH EXAMINATION; MOUTH SQUAMOUS CELL CARCINOMA; NON INVASIVE PROCEDURE; ORAL RINSE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RAR BETA GENE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TMEFF2 GENE; TUMOR GENE;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; ONCOGENES; PROMOTER REGIONS, GENETIC; SALIVA; SENSITIVITY AND SPECIFICITY;

EID: 84865343917     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27417     Document Type: Article

References (38)

1. Warnakulasuriya S,. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009; 45: 309-316.
2. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004; 350: 1937-1944.
3. Bretthauer M,. Colorectal cancer screening. J Intern Med. 2011; 270: 87-98.
4. Yamamoto K, Yamazaki H, Kuroda C, et al. Diagnostic validity of high-density barium sulfate in gastric cancer screening: follow-up of screenees by record linkage with the Osaka Cancer Registry. J Epidemiol. 2010; 20: 287-294.
5. Elmore JG, Jackson SL, Abraham L, et al. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology. 2009; 253: 641-651.
6. Rethman MP, Carpenter W, Cohen EE, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010; 141: 509-520.
7. Kujan O, Glenny AM, Duxbury J, Thakker N, Sloan P,. Evaluation of screening strategies for improving oral cancer mortality: a Cochrane systematic review. J Dent Educ. 2005; 69: 255-265.
8. Shaw R,. The epigenetics of oral cancer. Int J Oral Maxillofac Surg. 2006; 35: 101-108.
9. Das PM, Singal R,. DNA methylation and cancer. J Clin Oncol. 2004; 22: 4632-4642.
10. Ogi K, Toyota M, Ohe-Toyota M, et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res. 2002; 8: 3164-3171.
11. Maruya S, Issa JP, Weber RS, et al. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin Cancer Res. 2004; 10: 3825-3830.
12. Radhakrishnan R, Kabekkodu S, Satyamoorthy K,. DNA hypermethylation as an epigenetic mark for oral cancer diagnosis [published online ahead of print June 8, 2011]. J Oral Pathol Med. 2011.
13. Ha PK, Califano JA,. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol. 2006; 7: 77-82.
14. Righini CA, de Fraipont F, Timsit JF, et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res. 2007; 13: 1179-1185.
15. Carvalho AL, Jeronimo C, Kim MM, et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res. 2008; 14: 97-107.
16. Nagler RM,. Saliva as a tool for oral cancer diagnosis and prognosis. Oral Oncol. 2009; 45: 1006-1010.
17. Kusumoto T, Hamada T, Yamada N, et al. Comprehensive epigenetic analysis using oral rinse samples: a pilot study [published online ahead of print August 6, 2011]. J Oral Maxillofac Surg. 2011.
18. Huang ZH, Li LH, Yang F, Wang JF,. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions. World J Gastroenterol. 2007; 13: 950-954.
19. King-Batoon A, Leszczynska JM, Klein CB,. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen. 2008; 49: 36-45.
20. Suzuki M, Hao C, Takahashi T, et al. Aberrant methylation of SPARC in human lung cancers. Br J Cancer. 2005; 92: 942-948.
21. Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J,. Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas [serial online]. J Exp Clin Cancer Res. 2010; 29: 26.
22. Huang KH, Huang SF, Chen IH, Liao CT, Wang HM, Hsieh LL,. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma. Clin Cancer Res. 2009; 15: 4174-4180.
23. Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z,. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Oral Oncol. 2011; 47: 702-708.
24. Hirose Y, Kondo K, Takizawa H, et al. Aberrant methylation of tumour-related genes in thymic epithelial tumours. Lung Cancer. 2009; 64: 155-159.
25. Yang E, Kang HJ, Koh KH, Rhee H, Kim NK, Kim H,. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers. Int J Cancer. 2007; 121: 567-575.
26. Burrell A, Foy C, Burns M,. Applicability of 3 alternative instruments for food authenticity analysis: GMO identification [serial online]. Biotechnol Res Int 2011: 838232, 2011.
27. Vanderschaeghe D, Szekrenyes A, Wenz C, et al. High-throughput profiling of the serum N-glycome on capillary electrophoresis microfluidics systems: toward clinical implementation of GlycoHepatoTest. Anal Chem. 2010; 82: 7408-7415.
28. Fackler MJ, McVeigh M, Mehrotra J, et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res. 2004; 64: 4442-4452.
29. Nishino K, Toyoda M, Yamazaki-Inoue M, et al. DNA methylation dynamics in human induced pluripotent stem cells over time [serial online]. PLoS Genet. 2011; 7: e1002085.
30. van Oijen MG, Slootweg PJ,. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev. 2000; 9: 249-256.
31. Ha PK, Califano JA,. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med. 2003; 14: 363-369.
32. Kulkarni V, Saranath D,. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol. 2004; 40: 145-153.
33. Yeh KT, Shih MC, Lin TH, et al. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma. Anticancer Res 22 (6C): 3971-3975, 2002.
34. Kresty LA, Mallery SR, Knobloch TJ, et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 2002; 62: 5295-5300.
35. Eads CA, Danenberg KD, Kawakami K, et al. MethyLight: a high-throughput assay to measure DNA methylation [serial online]. Nucleic Acids Res. 2000; 28: E32.
36. Li M, Chen WD, Papadopoulos N, et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol. 2009; 27: 858-863.
37. Arai E, Ushijima S, Fujimoto H, et al. Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis. 2009; 30: 214-221.
38. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000; 60: 5954-5958.